NPPB and pulmonary arterial hypertension: Although B type natriuretic peptide (BNP) and N-terminal pro-B type natriuretic peptide (NTproBNP) have also been established as predictors in pediatric patients with PAH [27]–[29], current identified molecular markers, such as growth factors and proteases have not been evaluated in pediatric populations.